Search Results

Return to List
Results 61–80 of 95
Title Date
61.

Performance Enhancing Anabolic Steroid Abuse in Women

Number 484

(Reaffirmed 2013)

ABSTRACT: Anabolic steroids are composed of testosterone and other substances related to testosterone that promote growth of skeletal muscle, increase hemoglobin concentration, and mediate secondary sexual characteristics. These substances have been in use since the 1930s to promote muscle growth,...

April 2011

PDF Format
62.

Methamphetamine Abuse in Women of Reproductive Age

Number 479

(Reaffirmed 2013)

ABSTRACT: Methamphetamine abuse has continued to increase in the United States since the late 1980s with its use spreading from the West Coast to areas across the country. Methamphetamine use in pregnancy endangers the health of the woman and increases the risk of low birth weight and small for ge...

March 2011

PDF Format
63.

Family History as a Risk Assessment Tool

Number 478

ABSTRACT: Family history plays a critical role in assessing the risk of inherited medical conditions and single gene disorders. Several methods have been established to obtain family medical histories, including the family history questionnaire or checklist and the pedigree. The screening tool sel...

March 2011

PDF Format
64.

The Role of the Obstetrician Gynecologist in the Early Detection of Epithelial Ovarian Cancer

Number 477

(Replaces No. 280, December 2002)

ABSTRACT: Epithelial ovarian cancer is most commonly detected in an advanced stage, when the overall 5-year survival rate is 20–30%. Detection of early-stage ovarian cancer results in improved survival. Currently, there is no effective strategy for ovarian cancer screening. Women with persistent a...

March 2011

PDF Format
65.

Ethical Considerations for Performing Gynecologic Surgery in Low-Resource Settings Abroad

Number 466

(Reaffirmed 2013)

ABSTRACT: International humanitarian medical efforts provide essential services to patients who would not otherwise have access to specific health care services. The Committees on Ethics and Global Women's Health of the American College of Obstetricians and Gynecologists encourage College Fellows ...

September 2010

PDF Format
66.

Use of Hysterosalpingography After Tubal Sterilization

Number 458

ABSTRACT: The U.S. Food and Drug Administration has approved two devices for hysteroscopic tubal sterilization. To minimize the failure rates of these effective methods, it is important for health care providers to understand the important role hysterosalpingography (HSG) plays in any hysteroscop...

June 2010

PDF Format
67.

Increasing Use of Contraceptive Implants and Intrauterine Devices To Reduce Unintended Pregnancy

Number 450

(Reaffirmed 2011)

ABSTRACT: High unintended pregnancy rates in the United States may in part be the result of relatively low use of long-acting reversible contraceptive (LARC) methods, specifically the contraceptive implant and intrauterine devices. Top-tier reversible methods share the characteristic of requiring ...

December 2009

PDF Format
68.

Menstrual Manipulation for Adolescents With Disabilities

Number 448

(Reaffirmed 2012)

ABSTRACT: Defining the reasons for intervention and the precise goal of treatment are the most critical issues regarding use of interventions to alter menstrual flow in adolescents with disabilities. Reasons for intervention may relate to abnormal uterine bleeding, hygiene, mood issues, fear of pr...

December 2009

PDF Format
69.

Choosing the Route of Hysterectomy for Benign Disease

Number 444

(Reaffirmed 2011)

ABSTRACT: Hysterectomies are performed vaginally, abdominally, or with laparoscopic or robotic assistance. When choosing the route and method of hysterectomy, the physician should take into consideration how the procedure may be performed most safely and cost-effectively to fulfill the medical nee...

November 2009

PDF Format
70.

The Role of Transvaginal Ultrasonography in the Evaluation of Postmenopausal Bleeding

Number 440

(Reaffirmed 2013)

ABSTRACT: The clinical approach to postmenopausal bleeding requires prompt and efficient evaluation to exclude or diagnose carcinoma. Women with postmenopausal bleeding may be assessed initially with either endometrial biopsy or transvaginal ultrasonography; this initial evaluation does not requir...

August 2009

PDF Format
71.

Induced Abortion and Breast Cancer Risk

Number 434

(Reaffirmed 2013, Replaces No. 285, August 2003)

ABSTRACT: The relationship between induced abortion and the subsequent development of breast cancer has been the subject of a substantial amount of epidemiologic study. Early studies of the relationship between prior induced abortion and breast cancer risk were methodologically flawed. More rigoro...

June 2009

PDF Format
72.

Preimplantation Genetic Screening for Aneuploidy

Number 430

(Reaffirmed 2014)

ABSTRACT: Preimplantation genetic screening differs from preimplantation genetic diagnosis for single gene disorders and was introduced for the detection of chromosomal aneuploidy. Current data does not support a recommendation for preimplantation genetic screening for aneuploidy using fluorescenc...

March 2009

PDF Format
73.

Misoprostol for Postabortion Care

Number 427

ABSTRACT: The World Health Organization estimates that 67,000 women, mostly in developing countries, die each year from untreated or inadequately treated abortion complications. Postabortion care, a term commonly used by the international reproductive health community, refers to a specific set of ...

February 2009

PDF Format
74.

Health Care for Undocumented Immigrants

Number 425

ABSTRACT: Undocumented immigrants are less likely than other residents of the United States to have health insurance. Their access to publicly funded health programs has become increasingly limited since the passage of welfare reform in 1996 and varies from state to state. This is reflected in les...

January 2009

PDF Format
75.

Abortion Access and Training

Number 424

ABSTRACT: Despite a decrease in abortion rates over the past decade, numerous political, social, and provider barriers limit access to abortion services. Barriers include state restrictions and mandates limiting access, lack of public funding for abortion services, and the decrease in abortion pro...

January 2009

PDF Format
76.

Aromatase Inhibitors in Gynecologic Practice

Number 412

(Reaffirmed 2012)

ABSTRACT: Aromatase inhibitors appear to be effective as an adjuvant treatment for early-stage and late-stage breast cancer. Their role in chemoprevention of breast cancer in high-risk patients remains to be defined. Side effects of aromatase inhibitors in postmenopausal women are due to estrogen-...

August 2008

PDF Format
77.

Ethical Issues in Genetic Testing

Number 410

ABSTRACT: Genetic testing is poised to play an increasing role in the practice of obstetrics and gynecology. To assure patients of the highest quality of care, physicians should become familiar with the currently available array of genetic tests and the tests' limitations. Clinicians should be abl...

June 2008

PDF Format
78.

Direct-to-Consumer Marketing of Genetic Testing

Number 409

ABSTRACT: Marketing of genetic testing, although similar to direct-to-consumer advertising of prescription drugs, raises additional concerns and considerations. These include issues of limited knowledge among patients and health care providers of available genetic tests, difficulty in interpretati...

June 2008

PDF Format
79.

End-of-Life Decision Making

Number 403

ABSTRACT: The purpose of this Committee Opinion is to discuss issues related to end–of–life care, including terms and definitions, ethical principles, legal constructs, physician–patient communication, and educational opportunities pertinent for specialists in obstetrics and gynecology. Assumption...

April 2008

PDF Format
80.

Surrogate Motherhood

Number 397

ABSTRACT: Ethical responsibilities are described for obstetrician–gynecologists who choose to participate in surrogacy arrangements by 1) advising couples who are considering surrogacy, 2) counseling potential surrogate mothers, 3) providing obstetric services for pregnant women participating in s...

February 2008

PDF Format